vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and POTLATCHDELTIC CORP (PCH). Click either name above to swap in a different company.
POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $196.0M, roughly 1.6× Axsome Therapeutics, Inc.). POTLATCHDELTIC CORP runs the higher net margin — 8.2% vs -14.6%, a 22.8% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 23.1%). POTLATCHDELTIC CORP produced more free cash flow last quarter ($50.1M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 11.1%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
POTLATCHDELTIC CORPPCHEarnings & Financial Report
PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.
AXSM vs PCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $314.2M |
| Net Profit | $-28.6M | $25.9M |
| Gross Margin | — | 18.2% |
| Operating Margin | -13.8% | 11.2% |
| Net Margin | -14.6% | 8.2% |
| Revenue YoY | 65.0% | 23.1% |
| Net Profit YoY | 61.9% | 682.5% |
| EPS (diluted) | $-0.55 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | — | ||
| Q3 25 | $171.0M | $314.2M | ||
| Q2 25 | $150.0M | $275.0M | ||
| Q1 25 | $121.5M | $268.3M | ||
| Q4 24 | $118.8M | $258.1M | ||
| Q3 24 | $104.8M | $255.1M | ||
| Q2 24 | $87.2M | $320.7M | ||
| Q1 24 | $75.0M | $228.1M |
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-47.2M | $25.9M | ||
| Q2 25 | $-48.0M | $7.4M | ||
| Q1 25 | $-59.4M | $25.8M | ||
| Q4 24 | $-74.9M | $5.2M | ||
| Q3 24 | $-64.6M | $3.3M | ||
| Q2 24 | $-79.3M | $13.7M | ||
| Q1 24 | $-68.4M | $-305.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | — | 13.0% | ||
| Q1 25 | — | 17.8% | ||
| Q4 24 | — | 13.4% | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 11.9% | ||
| Q1 24 | — | 7.0% |
| Q4 25 | -13.8% | — | ||
| Q3 25 | -27.0% | 11.2% | ||
| Q2 25 | -24.5% | 5.0% | ||
| Q1 25 | -46.9% | 10.3% | ||
| Q4 24 | -61.1% | 5.2% | ||
| Q3 24 | -59.8% | 2.8% | ||
| Q2 24 | -89.5% | 5.4% | ||
| Q1 24 | -89.7% | -2.1% |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -27.6% | 8.2% | ||
| Q2 25 | -32.0% | 2.7% | ||
| Q1 25 | -48.9% | 9.6% | ||
| Q4 24 | -63.1% | 2.0% | ||
| Q3 24 | -61.7% | 1.3% | ||
| Q2 24 | -91.0% | 4.3% | ||
| Q1 24 | -91.1% | -0.1% |
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | $0.33 | ||
| Q2 25 | $-0.97 | $0.09 | ||
| Q1 25 | $-1.22 | $0.33 | ||
| Q4 24 | $-1.54 | $0.07 | ||
| Q3 24 | $-1.34 | $0.04 | ||
| Q2 24 | $-1.67 | $0.17 | ||
| Q1 24 | $-1.44 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $88.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $1.9B |
| Total Assets | $689.8M | $3.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | $88.8M | ||
| Q2 25 | $303.0M | $95.3M | ||
| Q1 25 | $300.9M | $147.5M | ||
| Q4 24 | $315.4M | $151.6M | ||
| Q3 24 | $327.3M | $161.1M | ||
| Q2 24 | $315.7M | $199.7M | ||
| Q1 24 | $331.4M | $180.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $88.3M | — | ||
| Q3 25 | $73.7M | $1.9B | ||
| Q2 25 | $73.1M | $1.9B | ||
| Q1 25 | $53.2M | $2.0B | ||
| Q4 24 | $57.0M | $2.0B | ||
| Q3 24 | $92.9M | $2.1B | ||
| Q2 24 | $102.9M | $2.1B | ||
| Q1 24 | $144.0M | $2.2B |
| Q4 25 | $689.8M | — | ||
| Q3 25 | $669.3M | $3.2B | ||
| Q2 25 | $639.8M | $3.2B | ||
| Q1 25 | $596.7M | $3.3B | ||
| Q4 24 | $568.5M | $3.3B | ||
| Q3 24 | $561.5M | $3.3B | ||
| Q2 24 | $548.2M | $3.4B | ||
| Q1 24 | $545.7M | $3.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $65.7M |
| Free Cash FlowOCF − Capex | $-18.7M | $50.1M |
| FCF MarginFCF / Revenue | -9.6% | 15.9% |
| Capex IntensityCapex / Revenue | 0.0% | 4.9% |
| Cash ConversionOCF / Net Profit | — | 2.54× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $132.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | $65.7M | ||
| Q2 25 | $-32.4M | $41.0M | ||
| Q1 25 | $-43.4M | $49.1M | ||
| Q4 24 | $-26.2M | $45.4M | ||
| Q3 24 | $-18.6M | $26.5M | ||
| Q2 24 | $-30.1M | $100.6M | ||
| Q1 24 | $-53.5M | $16.0M |
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | $50.1M | ||
| Q2 25 | $-32.4M | $30.6M | ||
| Q1 25 | $-43.7M | $26.3M | ||
| Q4 24 | $-26.2M | $25.4M | ||
| Q3 24 | $-18.7M | $-8.2M | ||
| Q2 24 | $-30.2M | $72.4M | ||
| Q1 24 | $-53.6M | $2.0M |
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | 15.9% | ||
| Q2 25 | -21.6% | 11.1% | ||
| Q1 25 | -36.0% | 9.8% | ||
| Q4 24 | -22.1% | 9.9% | ||
| Q3 24 | -17.9% | -3.2% | ||
| Q2 24 | -34.6% | 22.6% | ||
| Q1 24 | -71.4% | 0.9% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 4.9% | ||
| Q2 25 | 0.0% | 3.8% | ||
| Q1 25 | 0.3% | 8.5% | ||
| Q4 24 | 0.0% | 7.7% | ||
| Q3 24 | 0.1% | 13.6% | ||
| Q2 24 | 0.1% | 8.8% | ||
| Q1 24 | 0.1% | 6.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 5.58× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 8.74× | ||
| Q3 24 | — | 7.99× | ||
| Q2 24 | — | 7.35× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
PCH
| Lumber | $131.8M | 42% |
| Timberlands | $52.5M | 17% |
| Rural Real Estate | $51.3M | 16% |
| Residuals And Panels | $34.0M | 11% |
| Pulpwood | $16.7M | 5% |
| Development Real Estate | $14.6M | 5% |
| Other | $8.1M | 3% |
| Other Products | $5.2M | 2% |
